Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9P9J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,620
Award facts
- Contract value 100% obligated
- $7,620.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $7,620.30 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes, with an ultimate completion date of December 12, 2025. This contract represents a non-competitive, firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems.
This delivery order falls within AmerisourceBergen's broader responsibilities under the DLA pharmaceutical prime vendor agreement to supply comprehensive medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. Orencia (abatacept) is a biologic immunosuppressant used primarily for treating rheumatoid arthritis and other autoimmune conditions, reflecting the range of specialty medications the company provides through its federal contract portfolio. As a child contract under the larger SPE2DX vehicle, this order demonstrates AmerisourceBergen's ongoing role in fulfilling DLA's pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9P9J?
SPE2DR26F9P9J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F9P9J worth?
The government has obligated $7,620 on SPE2DR26F9P9J.
Is contract SPE2DR26F9P9J an order under another contract?
Yes. SPE2DR26F9P9J is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P9J competed?
The extent of competition for SPE2DR26F9P9J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award